Clinical practice of clinical pharmacists in treating myalgia and pharyngalgia caused by COVID-19 infection
Objective To explore the treatment scheme of muscle soreness(hereinafter referred to as myalgia)and pharyngalgia in patients with Corona Virus Disease 2019(hereinafter referred to as COVID-19 patients),so as to provide reference for the treatment of myalgia and pharyngalgia in COVID-19 patients.Methods The clinical pharmacist used clinical pharmaceutical thinking to analyze the reasons for the poor effect of a case of COVID-19 patient using non steroidal anti-inflammatory drugs(NSAIDs)in the treatment of myalgia and pharyngalgia,adjust the treatment plan of analgesic drugs,evaluate the potential risks of the medication plan,carry out drug education,prevent adverse drug events,and observe the analgesic effect.Results The addition of pregabalin capsule and lidocaine aerosol on the basis of the use of diclofenac sodium dual release enteric-coated capsules alleviated the myalgia and pharyngalgia of COVID-19 patients.Conclusion Through pharmaceutical services,clinical pharmacists have optimized the patient's analgesic treatment plan,alleviated the patient's pain,and provided a reference for the treatment of myalgia and pharyngalgia in COVID-19 patients.
万方数据
维普
